Reforming drug-control policy for palliative care in Romania

Instead of teaching for 2 days, JR called together 30 professionals, including consultants, nurses, ministers of health, representatives of the Drug Administration and Control Agency, pharmacists, and administrators, to examine the obstacles that prevented morphine being available for palliative car...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2006-06, Vol.367 (9528), p.2040-2041
Main Authors: Riley, Julia, Ross, Joy R
Format: Article
Language:English
Subjects:
Analgesics
Developing Countries
Drug and Narcotic Control - legislation & jurisprudence
Drug and Narcotic Control - statistics & numerical data
Drug therapy
Health Policy
Health Services Accessibility
Human rights
Humans
Medical treatment
Neoplasms
Palliative care
Palliative Care - statistics & numerical data
Palliative Care - utilization
Romania
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Instead of teaching for 2 days, JR called together 30 professionals, including consultants, nurses, ministers of health, representatives of the Drug Administration and Control Agency, pharmacists, and administrators, to examine the obstacles that prevented morphine being available for palliative care. In February, 2002, the Pain & Policy Studies Group,8 the European Regional Office of WHO, and the Open Society Institute sponsored a workshop entitled Assuring availability of opioid analgesics for palliative care.9 One of the three main reasons for Romania being selected to be a pilot country was because palliative care leaders were eager to address this problem of assuring access to opioid analgesics.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(06)68483-3